For the Inventor, By the Inventor

Enter assignee name

Biochem Pharma Inc.

USPTO Granted Patents = 62

Forward Citations = 1,199

Loading Chart...

Loading Chart...

85 inventors (with patents filed for the assignee):

Nghe Nguyen-Ba (18 out of 28 patents)

Tarek S Mansour (15 out of 17 patents)

Boulos Zacharie (10 out of 29 patents)

4. Haolun Jin (10 out of 12 patents)

5. Allan H Tse (9 out of 10 patents)

6. Bernard Belleau, Deceased (7 out of 8 patents)

7. Giorgio Attardo (6 out of 19 patents)

8. Gervais Dionne (6 out of 16 patents)

9. Rabindra Rej (5 out of 9 patents)

10. Dilip M Dixit (5 out of 9 patents)

11. M Arshad Siddiqui (5 out of 6 patents)

12. Yves St-Denis (5 out of 5 patents)

13. Bernard R Belleau (5 out of 16 patents)

14. Serge Lamothe (4 out of 6 patents)

15. Guy Falardeau (4 out of 10 patents)

Core Competencies:

Nucleoside Analogues

Antiviral Compounds

Flavivirus Infections

Integrin Inhibitors

Stereoselective Synthesis

Antineoplastic Heteronapthoquinones

Immunomodulating Activity

1,3-Oxathiolanes

Dioxolane Nucleosides

Neuroprotective Activity

Thrombin Inhibitors

Heterocyclic Compounds

62 patents: Sort by Forward Citations

1. 6903224 - Substituted 1,3-oxathiolanes (2005-06-07),

2. 6784161 - Method for the treatment or prevention of flavivirus infections using nucleoside analogues (2004-08-31),

3. 6747036 - Methods of treating leukemia (2004-06-08),

4. 6743910 - Stereoselective synthesis of nucleoside analogues (2004-06-01),

5. 6630488 - Quinolizinones as integrin inhibitors (2003-10-07),

6. 6630480 - Methods of treating leukemia (2003-10-07),

7. 6605614 - [1,8] naphthyridine derivatives having antiviral activity (2003-08-12),

8. 6583149 - Method for the treatment or prevention of viral infection using nucleoside analogues (2003-06-24),

9. 6566365 - Method for the treatment of Flaviviridea viral infection using nucleoside analogues (2003-05-20),

10. 6545001 - Antiviral nucleoside analogues (2003-04-08),

11. 6541625 - Stereoselective synthesis of nucleoside analogues (2003-04-01),

12. 6534520 - Antiviral compounds (2003-03-18),

13. 6511983 - Pharmaceutical combination of antiviral agents (2003-01-28),

14. 6444656 - Antiviral phosphonate nucleotides (2002-09-03),

15. 6369066 - Substituted 1,3-oxathiolanes with antiviral properties (2002-04-09),

BioChem Pharma Inc. is a leading pharmaceutical company specializing in the research, development, and production of innovative healthcare solutions. With a focus on discovering new treatments for various diseases, our dedicated teams of scientists and professionals work tirelessly to improve patient health and well-being. We are committed to delivering high-quality products that meet the highest standards of safety and efficacy. Visit our website to learn more about our cutting-edge research, pipeline, and global presence.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

62 Patents

#1 in Laval

#199 in Canada

#11,348 in the World

Biochem Pharma Inc.

Forward Citations = 1,199

85 inventors:

Nghe Nguyen-Ba (18 out of 28 patents)

Tarek S Mansour (15 out of 17 patents)

Boulos Zacharie (10 out of 29 patents)

4. Haolun Jin (10 out of 12 patents)

5. Allan H Tse (9 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…